Evaluation of the Serum Levels of IL-1 in Type 2 Diabetic Patients with and without Diabetic Nephropathy

Journals Menu

Follow SCIRP

ISSN Print: 2160-5831
ISSN Online: 2160-5858
www.scirp.org/journal/jdm
E-mail: jdm@scirp.org

"Evaluation of the Serum Levels of IL-1 in Type 2 Diabetic Patients with and without Diabetic Nephropathy"
written by Nahid Niknami, Melody Omraninava, Nazanin Mirzaei,
published by Journal of Diabetes Mellitus, Vol.8 No.2, 2018

has been cited by the following article(s):

[1]	Association of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms and plasma levels with diabetic nephropathy
	BioMed Research …, 2022

[2]	PERBEDAAN KADAR INTERLEUKIN-1 DAN MATRIX METALLOPROTEINASE-13 ANTARA PASIEN OSTEOARTRITIS GENU DENGAN DAN TANPA DIABETES …
	2022

[3]	Association of Interleukin‐1 Beta and Interleukin‐1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy
	BioMed Research …, 2022

[4]	Evaluation of the Genetic Association and Expressions of Notch-2/Jagged-1 in Patients with Type 2 Diabetes Mellitus
	2021

[5]	Impact of Interleukin-1 beta gene allelic polymorphisms in diabetic and non-diabetic hemodialysis Iraqi patients
	2020

[1]	Serum L C3-II levels in type 2 diabetic patients with impaired renal functions Cytokine, 2024 DOI:10.1016/j.cyto.2024.156683

[2]	Serum L C3-II levels in type 2 diabetic patients with impaired renal functions Cytokine, 2024 DOI:10.1016/j.cyto.2024.156683

[3]	Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy BioMed Research International, 2022 DOI:10.1155/2022/9661823

[4]	Association of Interleukin‐1 Beta and Interleukin‐1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy BioMed Research International, 2022 DOI:10.1155/2022/9661823

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top